May 28, 2020
Hikma launches Dicyclomine Hydrochloride Oral Solution
May 14, 2020
SciMount announces FDA approval of SMP-100's IND application for the treatment of Irritable Bowel Syndrome
May 07, 2020
Global Gastrointestinal Disorders Pipeline Database 2020: Key Products, Emerging Therapies, Leading Companies
May 05, 2020
Unprecedented 3-Year Safety Data Unveiled At Digestive Disease Week (DDW) Indicates No Pattern Of Heartburn With IBgard®, An Advanced Technology Peppermint Oil, Contrary To Heartburn Issues With Older Technologies
Apr 09, 2020
IFFGD's IBS Patients' Illness Experience and Unmet Needs Survey
Apr 01, 2020
For IBS Awareness Month, a free trial offer to help improve IBS symptoms
Mar 26, 2020
Allergan and Bausch Health Identified as the Top Companies Driving Therapeutic Innovation in IBS
Mar 09, 2020
The irritable bowel syndrome treatment market was valued at $1,071 million in 2018, and is estimated to reach at $2,012 million by 2026, registering a CAGR of 8.2% from 2019 to 2026
Mar 09, 2020
In A Peer-Reviewed Article In A Leading Gastroenterology Journal, Nonprescription FDgard® Is Added To Treatment Algorithm For The Management Of Functional Dyspepsia (FD)
Mar 09, 2020
Canadians suffering from diarrhea-predominant Irritable Bowel Syndrome (IBS-D) have a new clinically proven option approved by Health Canada
Feb 17, 2020
Irritable Bowel Syndrome Treatment Market to Reach $2.01 Bn, Globally, by 2026 at 8.2% CAGR, Says Allied Market Research
Jan 27, 2020
Irritable Bowel Syndrome (IBS) Product Earns Top Spot from TopConsumerReviews.com
Jan 10, 2020
Mahana Therapeutics Enters Into Licensing Agreement With King's College London for Innovative Digital Therapeutic to Treat Gastrointestinal Condition
Dec 19, 2019
ModifyHealth(TM) Aims to Help Millions of IBS Patients as the First Meal Delivery Service to Ship Low-FODMAP and Gluten-Free Meals Nationwide
Oct 31, 2019
Salix Announces Issuance of an Additional XIFAXAN® Patent
Oct 30, 2019
Study Shows Human Milk Oligosaccharides Significantly Improve IBS Symptoms
Oct 14, 2019
Global Irritable Bowel Syndrome (IBS) Therapeutics Industry
Sep 26, 2019
Synthetic Biologics Strengthens U.S. Patent Coverage of SYN-010, Intended for the Novel Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)
Sep 17, 2019
Ardelyx to Present at the Ladenburg Thalmann 2019 Healthcare Conference
Sep 09, 2019
ExeGi Pharma Probiotics to be Studied in Multiple Sclerosis Patients